Skip to content

Prediction Model for Anemia After Bariatric Surgery

Prediction Model for Anemia After Bariatric Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06170749
Enrollment
600
Registered
2023-12-14
Start date
2017-09-01
Completion date
2025-05-31
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Bariatric Surgery

Keywords

Anemia, Bariatric surgery, Prediction model

Brief summary

To develop and validate a prediction model for estimating the short and long-term risk of anemia after bariatric surgery.

Detailed description

This study aims to develop and validate a prediction model for estimating the probability of anemia for patients with obesity one, three, and five years after sleeve gastrectomy and Roux-en-Y gastric bypass, using preoperative clinical and laboratory data.

Interventions

None listed

Sponsors

The Third Xiangya Hospital of Central South University
CollaboratorOTHER
Jining First People's Hospital
CollaboratorOTHER
The Second Hospital of Shandong University
CollaboratorOTHER
China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
16 Years to 70 Years

Inclusion criteria

* aged between 16-70 years; * body mass index (BMI) ≥ 27.5 kg/m2; * complete preoperative and follow-up data.

Exclusion criteria

* vegetarian; * other bariatric procedures; * renal failure at baseline; * postoperative bleeding (it was defined as a drop in hemoglobin levels \> 3 g/dL or a confirmed blood loss requiring treatment after surgery); * incomplete preoperative and follow-up data.

Design outcomes

Primary

MeasureTime frameDescription
AUCs of the prediction model at 1, 3, 5 years5 yearsThis metric shows the discrimination ability of the prediction model.

Secondary

MeasureTime frameDescription
Brier score5 yearsThis metric shows the calibration of the model. The Brier score (on a scale ranging from 0 to 1), which calculates the difference between the estimated and observed risk for malignancy with values closer to 0 indicating better calibration, was used to evaluate model calibration.

Other

MeasureTime frameDescription
AUCs of the prediction model in different subgroups5 yearsAUCs of the prediction model in different subgroups, including age (≤ 40 years/\>40 years), sex, BMI (≤37.5kg/m2/\>37.5kg/m2), smoking history, alcohol consumption, hypertension, and T2DM history.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026